Atlas Trials

Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin

Clinical trial NCT05089357 · COMPLETED

Trial details

NCT number
NCT05089357
Sponsor
Galderma R&D
Status
COMPLETED
Study type
OBSERVATIONAL
Glabellar Lines
Start date
2021-11-11
Primary completion
2023-09-12
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.